EDGAR Filing Documents for 0001213900-21-013180

Form 8-K - Current report:

SEC Accession No. 0001213900-21-013180

Filing Date

2021-03-03

Accepted

2021-03-03 16:25:00

Documents

Period of Report

2021-02-25

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	ea136864-8k_180lifesciences.htm	8-K	50065
2	CONSULTANCY AGREEMENT DATED FEBRUARY 22, 2021, BY AND BETWEEN 180 LIFE SCIENCES	ea136864ex10-1_180lifesci.htm	EX-10.1	110630
3	AMENDED AND RESTATED EMPLOYMENT AGREEMENT DATED FEBRUARY 25, 2021, AND EFFECTIVE	ea136864ex10-2_180lifesci.htm	EX-10.2	65011
4	JAMES N. WOODY - STOCK OPTION AGREEMENT EFFECTIVE FEBRUARY 26, 2021 (1,400,000 S	ea136864ex10-3_180lifesci.htm	EX-10.3	58483
5	EMPLOYMENT AGREEMENT DATED FEBRUARY 24, 2021, AND EFFECTIVE NOVEMBER 6, 2020, BY	ea136864ex10-4_180lifesci.htm	EX-10.4	69404
6	OZAN PAMIR - STOCK OPTION AGREEMENT EFFECTIVE FEBRUARY 26, 2021 (180,000 SHARES)	ea136864ex10-5_180lifesci.htm	EX-10.5	61321
7	GRAPHIC	ex10-1_001.jpg	GRAPHIC	6603
	Complete submission text file	0001213900-21-013180.txt		425695

Mailing Address 150 WEST 56TH STREET SUITE 5901 NEW YORK NY 10019

Business Address 150 WEST 56TH STREET SUITE 5901 NEW YORK NY 10019 212-319-5555

180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)